The Washington Sun

Main Navigation

Subscribe Log in
  • Newsletters
    • Sign up for our newsletters
    • The Washington Sun newsletter
    • Afternoon Sun
    • Metro
    • Sign up for Dana Milbank’s newsletter
    • Sign up for Matt K. Lewis’ newsletter
  • Weather
  • Campaigns
    • 2026 Election
    • 2028 Election
    • Democrats
    • Republicans
    • Influence
  • Congress
    • House
    • Senate
  • Metro
    • Latest in Metro
    • Tom Sietsema
  • Sports
    • Latest in Sports
    • All-DMV High School
  • Policy
    • Administration
    • Defense
    • Energy & Environment
    • Immigration
    • Economy
    • Health
    • Foreign Policy
    • Housing
    • Technology
  • National
    • Legal
    • U.S. News
  • Perspectives
    • Latest Perspectives
    • Dana Milbank
    • Matt K. Lewis
    • Features
    • Forums
  • Podcast
    • Washington Sun Cast • Episode List
    • Listen on Apple Podcasts
    • Listen on Spotify
    • Watch on Youtube
  • Who Are We?
    • About The Washington Sun
    • Events
    • Work for us
    • Press Releases
    • Support FAQ
  • Follow Us
    • X (Twitter)
    • Bluesky
    • LinkedIn
    • Instagram
    • TikTok
    • YouTube
Subscribe
Log in

Support independent journalism. Subscribe for $50 for your first year. Limited time.

Health & Science

RFK Jr. Pulls Back on U.S. Investment in mRNA Vaccine Research

The Biomedical Advanced Research and Development Authority, or BARDA, is set to terminate 22 grants worth nearly $500 million.

Robert F. Kennedy, Jr.

Francis Chung/POLITICO via AP

By Amelia Benavides-Colón

August 5, 2025 07:28 p.m.

  • Email
  • LinkedIn
  • Twitter
  • Copy
    Link copied

The Department of Health and Human Services announced Tuesday it would begin a “coordinated wind-down” of its mRNA vaccine research.

Kennedy said in a press release that the Biomedical Advanced Research and Development Authority, or BARDA, would terminate 22 grants that support the production of new mRNA vaccines “because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.

“We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate,” he added. “We reviewed the science, listened to the experts, and acted.”

The total funding cut is worth nearly $500 million, according to Tuesday’s release. Contracts in their final stages, including with biomedical firms Arcturus and Amplitude, will be allowed to conclude, but the Global Health Investment Corporation, which runs BARDA, is directed to cease all other mRNA-based investments.

Trending

  • Kentucky Gov. Andy Beshear

    Andy Beshear’s Radical Proposition for America: We Could Have a Nice President.

  • Election 2026 Trump Commission

    Dana Milbank: 54 Ways Trump Has Tried to Sabotage the Election

  • Phil Scott Vermont

    Is Time Finally Running Out on Vermont’s Throwback Republican Governor — And Everything He Represents?

  • Rep. Haley Stevens.

    Haley Stevens Is Making Herself Michigan’s Main Character

Projects that will be cut include an award to Moderna for an mRNA-based h5N1 vaccine, contracts with Emory University and Tiba Biotech and the cancellation of multiple pre-award grants to Pfizer, Sanofi Pasteur, CSL Seqirus and Gristone, among others.

MRNA-related work in existing contracts, like with Luminary Labs, ModeX and Seqirus, will also be redirected, along with the restructuring of collaborations with the Department of Justice on nucleic acid-based vaccine projects with AAHI, AstraZeneca and HDT Bio.

Going forward, BARDA will focus on “platforms with stronger safety records and transparent clinical and manufacturing data practices,” according to Tuesday’s release.

“Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions — like whole-virus vaccines and novel platforms.”

Kennedy has a long history of questioning the safety of vaccines — including those using mRNA technology. His vaccine skepticism dates back to at least 2005, when he first published his theory that childhood vaccines may be tied to autism. Since then he has focused in particular on the vaccines created to fight the COVID-19 pandemic.

In early June, Kennedy also fired all 17 members of the Centers for Disease Control and Prevention’s vaccine recommendation committee, later replacing four of them with scientists with histories of vaccine skepticism.

Author

aji_fellow2024_ameliabenavides_colón.png Amelia Benavides-Colón is a former NOTUS reporter and Allbritton Journalism Institute fellow.

The Latest

  • Trump

    Troops ‘Can’t Feel Genuinely Safe’ as Trump Weighs Iran Escalation

  • The Binance logo

    FBI Blames North Korea for Stolen Billions From Binance in Biggest Hack in History

  • Democrats Abroad Get Out the Vote Action Hub

    Inside the Effort to Get Americans in Canada to Vote

  • President Donald Trump.

    Judge Throws Out Trump’s Suit Against the Wall Street Journal Over Epstein Letter

  • Rep. Haley Stevens.

    Haley Stevens Is Making Herself Michigan’s Main Character

Welcome back to The Washington Sun!

You can always update your profile and newsletters preferences on the My Account page.

Manage account settings

Welcome to
The Washington Sun

Subscribe to maintain unlimited access to independent journalism covering Washington's people, politics and power.

Continue to checkout ↗
  • About The Washington Sun
  • Work for us
  • Terms of Use
  • Subscription Agreement Terms and Conditions
  • Privacy Policy
  • Your CA Privacy Rights
  • Support FAQ
  • Contact us

© 2026.0 NOTUS MEDIA, LLC